| Product Code: ETC7623257 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Angina Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Angina Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Angina Market - Industry Life Cycle |
3.4 Ireland Angina Market - Porter's Five Forces |
3.5 Ireland Angina Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Ireland Angina Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.7 Ireland Angina Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ireland Angina Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Ireland |
4.2.2 Growing awareness about angina symptoms and treatment options |
4.2.3 Advancements in medical technology and treatment options for angina patients |
4.3 Market Restraints |
4.3.1 High cost associated with angina treatment and medications |
4.3.2 Limited access to specialized healthcare facilities in certain regions of Ireland |
4.3.3 Stringent regulatory requirements for the approval of angina-related drugs and therapies |
5 Ireland Angina Market Trends |
6 Ireland Angina Market, By Types |
6.1 Ireland Angina Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Ireland Angina Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Ireland Angina Market Revenues & Volume, By Beta Blockers, 2021- 2031F |
6.1.4 Ireland Angina Market Revenues & Volume, By Nitrates and Calcium Channel Blockers, 2021- 2031F |
6.1.5 Ireland Angina Market Revenues & Volume, By Angiotensin-Converting Enzyme Inhibitors, 2021- 2031F |
6.1.6 Ireland Angina Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Angina Market, By Types |
6.2.1 Overview and Analysis |
6.2.2 Ireland Angina Market Revenues & Volume, By Stable Angina and Unstable Angina, 2021- 2031F |
6.2.3 Ireland Angina Market Revenues & Volume, By Variant (Prinzmetal) Angina, 2021- 2031F |
6.2.4 Ireland Angina Market Revenues & Volume, By Microvascular Angina, 2021- 2031F |
6.3 Ireland Angina Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Ireland Angina Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Ireland Angina Market Revenues & Volume, By Cardiology Centers, 2021- 2031F |
6.3.4 Ireland Angina Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Angina Market Import-Export Trade Statistics |
7.1 Ireland Angina Market Export to Major Countries |
7.2 Ireland Angina Market Imports from Major Countries |
8 Ireland Angina Market Key Performance Indicators |
8.1 Average wait time for angina patients to receive medical treatment |
8.2 Patient satisfaction with angina treatment and care services |
8.3 Number of healthcare providers offering specialized angina treatment services |
9 Ireland Angina Market - Opportunity Assessment |
9.1 Ireland Angina Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Ireland Angina Market Opportunity Assessment, By Types, 2021 & 2031F |
9.3 Ireland Angina Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ireland Angina Market - Competitive Landscape |
10.1 Ireland Angina Market Revenue Share, By Companies, 2024 |
10.2 Ireland Angina Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here